Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic Approach
Nerve Block, Cleft Palate, Analgesia
About this trial
This is an interventional treatment trial for Nerve Block
Eligibility Criteria
Inclusion Criteria: Paediatric patients scheduled for cleft palate (CP) surgery with SMNB as part of their perioperative pain treatment American Society of Anesthesiologists physical status 1 - 2 Age 10 to 24 months Given informed written consent by legal guardian Exclusion Criteria: American Society of Anesthesiologists physical status > 2 Patients with cranial deformation Patients with concomitant medical treatments or medical conditions interfering with peripheral nerve block treatment Patients with concomitant medical treatments or medical conditions interfering with MRI Patients that are allergic to bupivacaine or other local anaesthetic agents.
Sites / Locations
- Oslo University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ultrasound guided Suprazygomatic Maxillary Nerve Block
Landmark guided Suprazygomatic Maxillary Nerve Block landmark
An ultasound guided SMNB is admitted on one half of the patients face (left or right) according to randomiced allocation. 0.15 ml/kg of bupivacaine 0.25 mg/ml with epinephrin 5 mcg/ml is injected.
A langmark guided SMNB is admitted on the other half of the patients face (left or right) according to randomiced allocation. 0.15 ml/kg of bupivacaine 0.25 mg/ml with epinephrin 5 mcg/ml is injected.